APA (7th ed.) Citation

Mantuano, P., Boccanegra, B., Conte, E., De Bellis, M., Cirmi, S., Sanarica, F., . . . De Luca, A. (2021). β-Dystroglycan Restoration and Pathology Progression in the Dystrophic mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation. Biomolecules (2218-273X), 11(11), 1742. https://doi.org/10.3390/biom11111742

Chicago Style (17th ed.) Citation

Mantuano, Paola, et al. "β-Dystroglycan Restoration and Pathology Progression in the Dystrophic Mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation." Biomolecules (2218-273X) 11, no. 11 (2021): 1742. https://doi.org/10.3390/biom11111742.

MLA (9th ed.) Citation

Mantuano, Paola, et al. "β-Dystroglycan Restoration and Pathology Progression in the Dystrophic Mdx Mouse: Outcome and Implication of a Clinically Oriented Study with a Novel Oral Dasatinib Formulation." Biomolecules (2218-273X), vol. 11, no. 11, 2021, p. 1742, https://doi.org/10.3390/biom11111742.